GLOBOCAN 2022

ALGERIA
Number of new cases Number of deaths Number of prevalent cases
(5-year)

64 713 35 778 177 718

Statistics at a glance, 2022
Males Females Both sexes
Population 22 912 687 22 437 454 45 350 141

Incidence* Algeria

Number of new cancer cases 29 387 35 326 64 713

Age-standardized incidence rate 130.6 152.2 141.2

Risk of developing cancer before the age 14.1 15.1 14.6

of 75 years (cum. risk %)

Top 3 leading cancers (ranked by Lung Breast Breast

cases)**
Colorectum Colorectum Colorectum
Prostate Thyroid Lung

Mortality*

Number of cancer deaths 18 809 16 969 35 778

Age-standardized mortality rate 82.7 73.1 77.7

Risk of dying from cancer before the age 8.7 7.8 8.2
of 75 years (cum. risk %)

Top 3 leading cancers (ranked by Lung Breast Breast

deaths)**
Colorectum Colorectum Lung
Bladder Cervix uteri Colorectum

Prevalence* Kilometers

0 250 500 1000

5-year prevalent cases 72 408 105 310 177 718

Top 5 most frequent cancers**

Males Females Both sexes

Lung
Breast

Others

Breast
Others Colorectum
Others

Colorectum

Prostate
Ovary
Lung
Cervix uteri

Stomach Bladder Thyroid Colorectum Prostate

Bladder

Total: 29 387 Total: 35 326 Total: 64 713

Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent

1st Lung 4 311 14.7% 1st Breast 14 601 41.3% 1st Breast 14 601 22.6%

2nd Colorectum 4 082 13.9% 2nd Colorectum 3 665 10.4% 2nd Colorectum 7 747 12.0%

3rd Prostate 3 514 12.0% 3rd Thyroid 2 089 5.9% 3rd Lung 5 040 7.8%

4th Bladder 2 770 9.4% 4th Cervix uteri 1 799 5.1% 4th Prostate 3 514 5.4%

5th Stomach 1 693 5.8% 5th Ovary 1 147 3.2% 5th Bladder 3 240 5.0%

- Others 13 017 44.3% - Others 12 025 34.0% - Others 30 571 47.2%

Number of new cases in 2022, males, all ages Number of new cases in 2022, females, all ages Number of new cases in 2022, both sexes, all ages

The Global Cancer Observatory | All rights reserved | Globocan 2022 (version 1.1) - 08.02.2024 Page 1
 Incidence, Mortality and Prevalence by cancer site

New cases Deaths 5-year prevalence

Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)

Breast 14 601 1 22.6 6.3 4 893 1 13.7 2.2 47 259 210.6

Colorectum 7 747 2 12.0 2.0 4 380 3 12.2 1.0 22 192 48.9

Lung 5 040 3 7.8 1.4 4 599 2 12.9 1.3 6 725 14.8

Prostate 3 514 4 5.4 1.9 1 333 7 3.7 0.19 8 124 35.5

Bladder 3 240 5 5.0 0.90 1 818 5 5.1 0.43 9 863 21.8

Stomach 2 785 6 4.3 0.72 2 250 4 6.3 0.57 4 330 9.6

Thyroid 2 519 7 3.9 0.55 358 19 1.0 0.07 8 599 19.0

NHL 2 226 8 3.4 0.51 1 187 8 3.3 0.27 7 118 15.7

Brain CNS 2 038 9 3.1 0.44 1 575 6 4.4 0.38 7 675 16.9

Cervix uteri 1 799 10 2.8 0.94 1 013 11 2.8 0.57 5 442 24.3

Leukaemia 1 731 11 2.7 0.34 1 167 9 3.3 0.24 5 323 11.7

Nasopharynx 1 608 12 2.5 0.37 971 12 2.7 0.26 5 125 11.3

Gallbladder 1 193 13 1.8 0.32 785 14 2.2 0.19 1 733 3.8

Pancreas 1 168 14 1.8 0.30 1 136 10 3.2 0.30 1 193 2.6

Ovary 1 147 15 1.8 0.57 795 13 2.2 0.44 3 444 15.4

Hodgkin lymphoma 999 16 1.5 0.18 278 20 0.78 0.06 3 649 8.1

Larynx 961 17 1.5 0.28 627 17 1.8 0.17 2 970 6.6

Multiple myeloma 770 18 1.2 0.21 655 16 1.8 0.18 2 154 4.8

Liver 755 19 1.2 0.19 663 15 1.9 0.17 1 010 2.2

Kidney 729 20 1.1 0.18 371 18 1.0 0.09 2 263 5.0

Corpus uteri 593 21 0.92 0.33 124 23 0.35 0.07 2 097 9.4

Lip, oral cavity 343 22 0.53 0.09 146 22 0.41 0.04 997 2.2

Melanoma 306 23 0.47 0.07 113 24 0.32 0.02 1 018 2.2

Oesophagus 285 24 0.44 0.06 266 21 0.74 0.06 413 0.91

Testis 163 25 0.25 0.06 29 30 0.08 0.01 611 2.7

Salivary glands 152 26 0.24 0.03 59 26 0.17 0.01 481 1.1

Vulva 97 27 0.15 0.05 36 29 0.10 0.02 277 1.2

Oropharynx 90 28 0.14 0.02 53 27 0.15 0.01 228 0.50

Hypopharynx 77 29 0.12 0.02 41 28 0.12 0.01 135 0.30

Mesothelioma 69 30 0.11 0.02 65 25 0.18 0.02 96 0.21

Kaposi sarcoma 62 31 0.10 0.01 28 31 0.08 0.00 124 0.27

Vagina 49 32 0.08 0.02 24 32 0.07 0.01 123 0.55

All cancers 64 713 - - 14.6 35 778 - - 8.2 177 718 -

All cancers excl. NMSC 63 306 - - 14.3 35 347 - - 8.2 173 172 -

Data source and methods

Incidence Incidence Mortality Males Females

Country-specific data source: Setif cancer registry, Algiers Breast 61.9 20.8 Breast 61.9

cancer registry, Batna cancer registry, Tlemcen cancer registry 17.1 9.4 19.5 3.2
Colorectum Lung

Method: Weighted/simple average of the most recent sub-

Prostate 15.5 5.1 Colorectum 18.2 15.9
national rates applied to 2022 population
Lung 11.3 10.4 Prostate 15.5

Click here to see detailed data source and methods Cervix uteri 8.0 4.6 Bladder 12.4 2.0

Bladder 7.2 3.9 Cervix uteri 8.0

Mortality Stomach 6.1 4.9 Stomach 7.6 4.7

Thyroid 5.4 0.8 NHL 5.7 4.1

Country-specific data source: No data
Method: Estimated from national mortality estimates by Ovary 5.0 3.6 Ovary 5.0

modelling, using mortality:incidence ratios derived from survival NHL 4.9 2.5 Nasopharynx 4.8 2.2

estimation Brain CNS 4.5 3.5 Brain CNS 4.8 4.2

Leukaemia 3.8 2.5 Leukaemia 4.3 3.3

Click here to see detailed data source and methods
Nasopharynx 3.5 2.2 Larynx 4.1 0.3

Prevalence Corpus uteri

Gallbladder
2.7

2.7
0.6

1.7
Pancreas

Corpus uteri
3.1 2.1

2.7

Computed using sex-; site- and age-specific incidence to 1-;3-

100 80 60 40 20 0 20 40 60 80 100 80 60 40 20 0 20 40 60 80
and 5-year prevalence ratios from Nordic countries for the period

(2011-2020), and scaled using Human Development Index (HDI)

ASR (World) incidence and mortality rates, top 15 cancers** ASR (World) incidence rates per sex, top 15 cancers**
ratios.

Page 2

* includes non-melanoma skin cancer (NMSC)

** NMSC included in other cancers

Age standardization using world population (see link)

References
Cancer incidence and mortality data
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:

Website citation GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.

2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).

Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:
from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].
An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.

© IARC 1965-2024 | All Rights Reserved | https://gco.iarc.who.int | https://gco.iarc.who.int/today